Navigation Links
Developmental Origins of Polycystic Ovarian Syndrome

A recent study has revealed that the way a baby girl develops in a womb may adversely affect// chances of developing polycystic ovarian syndrome (PCO) as adults. Dr Michael Davies, senior researcher at the Research Center of Reproductive Health at the University of Adelaide, Australia headed this study. Dr Davies and his team studied a group of young women bon between 1973 and 1975. They decided to first contact the mothers from maternity hospital records and then interview the daughters. So far 544 women have been interviewed, all who are aged between 30 and 32. The study included a detailed report on the medical history as well as birth details. The details also included birth weight, placental weight, and so on. After a wide comparison Dr Davies said: "Symptoms of PCOS were relatively common. One in five women had more facial and/or body hair than normal, and one in four reported menstrual irregularity of greater than four days. Five per cent of women reported that they had an existing diagnosis of PCOS. We examined maternal weight in late pregnancy, birth weight and placental weight in relation to the symptoms of PCOS, or an existing or putative diagnosis of PCOS. Compared with their counterparts, young women without a diagnosis of PCOS but with irregular periods were heavier at birth, with larger placentas, and they tended to have mothers who were heavier in late pregnancy. In contrast, women with an existing diagnosis of PCOS tended to have birth weights that were, on average, 196g lighter than women without PCOS and smaller placentas”.

He further said, “Therefore, our data suggest that different developmental pathways are implicated in the overlapping symptoms of PCOS. One pathway may be mediated by high maternal weight in late pregnancy, which is linked to irregular periods in the daughter, and possibly obesity and weight-related reproduction problems. A second pathway may involve reduced placental and foetal growth, which is linked to the more sev
'"/>




Page: 1 2

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Pre Mature Babies Face the Risk Developmental Abnormalities
3. Developmental Delays in Infants Linked to DDT
4. MRI Scans in Premature Infants Can Predict Future Developmental Delays
5. Emotional Problems Common Among Children With Developmental Disabilities
6. Missing Molecule Has Important Role in a Developmental Brain Abnormality
7. Developmental And Behavioral Problems Can Plague Children With Asthma
8. Team Tracks Genetic Origins of Eye Cancer
9. Genetic Fingerprints Identify Brain Tumors Origins
10. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
11. Polycystic Ovary In Women May Raise Liver Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Developmental Origins Polycystic Ovarian Syndrome

(Date:12/26/2014)... December 26, 2014 Plugin and template developers ... Volume 5 Plugin for Final Cut Pro X. , “TransPack ... light tool to pull off an industry professional look” Said ... their hands on TransPack Volume 5, a new level of ... a set of over 50 Final Cut Pro X transitions ...
(Date:12/26/2014)... December 26, 2014 Pentec Health, Inc. ... the state of Pennsylvania for 2014. The awards program, ... programs of its kind in the country. The program ... Pennsylvania Department of Community and Economic Development, the Pennsylvania ... and the Central Penn Business Journal. , ...
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 ... Market Analysis to 2023” focuses on the current ... opportunities in the colorectal cancer market. Stivarga is ... of colon or rectal cancer. Boehringer Ingelheim is ... for the treatment of refractory CRC in the ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
Breaking Medicine News(10 mins):Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... Forest Laboratories, Inc.,(NYSE: FRX ), an international ... Fiscal 2008 Third Quarter financial results,before the U.S. ... Later that,day, at 10:00 AM EST, Forest will ... and Chief Operating Officer and Frank Perier, Senior,Vice ...
... Torchmark Corporation,(NYSE: TMK ) announced today ... subsidiaries, United American Life Insurance Company, and Globe,Life ... Torchmark,plans to redomesticate other of its subsidiaries to ... in a number of states, as well as ...
... CORONA, Calif., Jan. 2 Watson,Pharmaceuticals, Inc. (NYSE: ... today that it has received final approval from ... on its Abbreviated,New Drug Application (ANDA) for Ipratropium ... mg/3 mg strength., Watson,s Ipratropium Bromide and ...
... Laboratories, Inc.,announced today the approval of its ... Tablets, 1mg by the U.S. Food and ... Dose Blisters and is,available for immediate shipment ... http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO ), Roxane Laboratories, ...
... BEDFORD, Ohio, Jan. 3 Bedford Laboratories(TM), ... the acquisition of,CAFCIT(R) (caffeine citrate) Injection and ... & Company. Bedford Laboratories is now the,reference ... indicated for,the short term treatment of apnea ...
... risk for malignancy, experts say , , THURSDAY, Jan. 3 ... children who have cancer also have more body anomalies, ... , This suggests that the same genetic defect underlies ... genetic information may help identify individuals predisposed to develop ...
Cached Medicine News:Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings 2Health News:Watson Receives FDA Approval for Generic DuoNeb(R) 2Health News:Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg 2Health News:Bedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral Solution 2Health News:Body Abnormalities, Childhood Cancer May Share Genes 2Health News:Body Abnormalities, Childhood Cancer May Share Genes 3
(Date:12/24/2014)... 24, 2014 /CNW/ -   ... after Health Canada tests confirmed it contains two undeclared ... and phenylpropylmethylamine). The distributor, Empire Health Distribution of ... from retail stores across Canada . ... for weight loss and increased energy. ...
(Date:12/24/2014)... BUFFALO, N.Y. , Dec. 24, 2014 ... been dosed with KX2-361 at Roswell Park Cancer Institute. ... a small molecule drug that has shown potent inhibitory ... lines, including those that are resistant to Temozolomide (T98G), ... malignant glioma. In a well-established brain tumor mouse model, ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... 2,050,000 shares of its common stock and Series ... common stock.  Funds under the management of QVT ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
Lightweight PVC housing for easy transport, integrated handle. Easy lamp exchange....
... important diagnostic tool in determining functionality ... important when deciding courses of treatment ... treatment, recurring infections and autoimmune dieseases. ... patients with autoimmune diseases giving rise ...
Maximum brightness, durability, universal power suply, microprocessor-controlled light output and, in the event of lamp failure or degredation, automatic switchover to an integraged spare lamp....
Tested by surgeons for functionality and ergonomy. Uses the Medifix C3-3001-3CCD camera head....
Medicine Products: